Axel Capital Management’s Eli Lilly LLY Stock Holding History

Axel Capital Management’s Portfolio LLY Stock Details LLY Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2016 Q2	–	Sell	-20,260	Closed	-$1.46M	–	18
2016 Q1	$1.46M	Hold	20,260	–	–	0.77%	10
2015 Q4	$1.71M	Hold	20,260	–	–	0.98%	11
2015 Q3	$1.7M	Hold	20,260	–	–	1.04%	13
2015 Q2	$1.69M	Buy	20,260 +10,000	+97%	+$762K	1.19%	14
2015 Q1	$745K	Hold	10,260	–	–	0.52%	25
2014 Q4	$708K	Buy	10,260 +10,000	+3,846%	+$675K	0.69%	25
2014 Q3	$17K	Hold	260	–	–	0.02%	32
2014 Q2	$16K	Hold	260	–	–	0.03%	31
2014 Q1	$15K	Hold	260	–	–	0.03%	39
2013 Q4	$13K	Hold	260	–	–	0.06%	30
2013 Q3	$13K	Hold	260	–	–	0.34%	21
2013 Q2	$13K	Buy	+260	New	+$14.1K	1.62%	21

Other funds holding LLY

Lilly Endowment Indiananapolis, Indiana $84.5B AUM 11.36% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Primecap Management Pasadena, California $127B AUM 44.11% 1-Year Est. Return

Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Franklin Resources San Mateo, California $408B AUM 30.18% 1-Year Est. Return

BIT

BlackRock Institutional Trust San Francisco, California $675B AUM 16.07% 1-Year Est. Return

JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return

State Farm Mutual Automobile Insurance Bloomington, Illinois $127B AUM 32.55% 1-Year Est. Return

BFA

BlackRock Fund Advisors San Francisco, California $542B AUM 18.13% 1-Year Est. Return

Axel Capital Management's LLY Position: Q2 2016 in Review

Axel Capital Management sold out of Eli Lilly (LLY) in Q2 2016, closing a stake of 20,260 shares — an estimated $1.46M sold.

Axel Capital Management first reported a position in LLY in Q2 2013 and held it in 12 quarters. The position peaked at $1.71M in Q4 2015. 1,179 funds tracked by Wall St. Rank hold LLY as of Q2 2016.

Axel Capital Management reported no remaining Eli Lilly position as of Q2 2016 after selling out during the quarter.
Axel Capital Management sold 20,260 Eli Lilly shares in Q2 2016, an estimated $1.46M.
Axel Capital Management first reported a position in Eli Lilly in Q2 2013 and held it in 12 quarters.
Axel Capital Management's Eli Lilly position peaked at $1.71M in Q4 2015.
1,179 funds tracked by Wall St. Rank held Eli Lilly as of Q2 2016.

Based on Axel Capital Management's 13F filing for Q2 2016, filed 11 Aug 2016.